Omni Partners’s Advent Technologies ADN Stock Holding History

Omni Partners’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,422	Closed	-$1.08M	–	248
2020 Q4	$1.08M	Buy	+2,422	New	+$838K	0.06%	147

Other funds holding ADN

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PSCM

Prince Street Capital Management New York $40.3M AUM 0.66% 1-Year Est. Return

SAM

Storebrand Asset Management Lysaker, Norway $40.6B AUM 38.65% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Omni Partners's ADN Position: Q1 2021 in Review

Omni Partners sold out of Advent Technologies (ADN) in Q1 2021, closing a stake of 2,422 shares — an estimated $1.08M sold.

Omni Partners first reported a position in ADN in Q4 2020 and held it in 1 quarter. The position peaked at $1.08M in Q4 2020. 45 funds tracked by Wall St. Rank hold ADN as of Q1 2021.

Omni Partners reported no remaining Advent Technologies position as of Q1 2021 after selling out during the quarter.
Omni Partners sold 2,422 Advent Technologies shares in Q1 2021, an estimated $1.08M.
Omni Partners first reported a position in Advent Technologies in Q4 2020 and held it in 1 quarter.
Omni Partners's Advent Technologies position peaked at $1.08M in Q4 2020.
45 funds tracked by Wall St. Rank held Advent Technologies as of Q1 2021.

Based on Omni Partners's 13F filing for Q1 2021, filed 17 May 2021.